EGFR and non-small cell lung carcinoma: As to tumor heterogeneity, the deep learning score of EGFR mutation provides a non-invasive method for identifying NSCLC patients sensitive to EGFR tyrosine kinase inhibitors or immune checkpoint inhibitors treatments (19).